China Biologic Produ (CBPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 566,862 | 545,138 | 122,856 | 161,750 | 220,850 |
| Marketable Securities | 536,484 | 495,833 | 868,778 | 765,507 | 620,510 |
| Receivables | 136,133 | 114,636 | 132,992 | 100,270 | 140,333 |
| Inventories | 234,465 | 225,578 | 214,439 | 250,728 | 243,849 |
| TOTAL | $1,494,958 | $1,402,519 | $1,360,021 | $1,299,725 | $1,258,987 |
| Non-Current Assets | |||||
| PPE Net | 180,065 | 172,369 | 173,330 | 177,597 | 176,184 |
| Investments And Advances | 26,100 | 25,965 | 26,508 | 27,538 | 27,370 |
| Intangibles | 385,457 | 371,788 | 373,044 | 381,036 | 382,370 |
| Other Non-Current Assets | 52,933 | 51,783 | 51,822 | 51,962 | 47,898 |
| TOTAL | $644,555 | $621,905 | $624,704 | $638,133 | $633,821 |
| Total Assets | $2,139,513 | $2,024,424 | $1,984,726 | $1,937,859 | $1,892,808 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 108,390 | 109,725 | 108,344 | 106,006 | 104,512 |
| TOTAL | $124,449 | $123,901 | $129,358 | $119,309 | $120,234 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 30,508 | 34,528 | 33,899 | 37,252 | 31,261 |
| TOTAL | $39,375 | $41,437 | $44,897 | $43,698 | $40,167 |
| Total Liabilities | $163,825 | $165,339 | $174,255 | $163,007 | $160,401 |
| Shareholders' Equity | |||||
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | 901,901 | 862,357 | 826,675 | 773,291 | 760,839 |
| Other shareholders' equity | 53,266 | -8,477 | -14,415 | 10,283 | -10,062 |
| TOTAL | $1,975,688 | $1,859,086 | $1,810,470 | $1,774,852 | $1,732,408 |
| Total Liabilities And Equity | $2,139,513 | $2,024,425 | $1,984,725 | $1,937,859 | $1,892,809 |